Cargando…
In Vitro and In Vivo Studies of Heraclenol as a Novel Bacterial Histidine Biosynthesis Inhibitor against Invasive and Biofilm-Forming Uropathogenic Escherichia coli
Globally, urinary tract infections (UTIs) are one of the most frequent bacterial infections. Uropathogenic Escherichia coli (UPEC) are the predominant etiological agents causing community and healthcare-associated UTIs. Biofilm formation is an important pathogenetic mechanism of UPEC responsible for...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854483/ https://www.ncbi.nlm.nih.gov/pubmed/36671311 http://dx.doi.org/10.3390/antibiotics12010110 |
_version_ | 1784873131381358592 |
---|---|
author | Kaur, Harpreet Chaudhary, Naveen Modgil, Vinay Kalia, Manmohit Kant, Vishal Mohan, Balvinder Bhatia, Alka Taneja, Neelam |
author_facet | Kaur, Harpreet Chaudhary, Naveen Modgil, Vinay Kalia, Manmohit Kant, Vishal Mohan, Balvinder Bhatia, Alka Taneja, Neelam |
author_sort | Kaur, Harpreet |
collection | PubMed |
description | Globally, urinary tract infections (UTIs) are one of the most frequent bacterial infections. Uropathogenic Escherichia coli (UPEC) are the predominant etiological agents causing community and healthcare-associated UTIs. Biofilm formation is an important pathogenetic mechanism of UPEC responsible for chronic and recurrent infections. The development of high levels of antimicrobial resistance (AMR) among UPEC has complicated therapeutic management. Newer antimicrobial agents are needed to tackle the increasing trend of AMR and inhibit biofilms. Heraclenol is a natural furocoumarin compound that inhibits histidine biosynthesis selectively. In this study, for the first time, we have demonstrated the antimicrobial and antibiofilm activity of heraclenol against UPEC. The drug reduced the bacterial load in the murine catheter UTI model by ≥4 logs. The drug effectively reduced bacterial loads in kidney, bladder, and urine samples. On histopathological examination, heraclenol treatment showed a reversal of inflammatory changes in the bladder and kidney tissues. It reduced the biofilm formation by 70%. The MIC value of heraclenol was observed to be high (1024 µg/mL), though the drug at MIC concentration did not have significant cytotoxicity on the Vero cell line. Further molecular docking revealed that heraclenol binds to the active site of the HisC, thereby preventing its activation by native substrate, which might be responsible for its antibacterial and antibiofilm activity. Since the high MIC of heraclenol is not achievable clinically in human tissues, further chemical modifications will be required to lower the drug’s MIC value and increase its potency. Alternatively, its synergistic action with other antimicrobials may also be studied. |
format | Online Article Text |
id | pubmed-9854483 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98544832023-01-21 In Vitro and In Vivo Studies of Heraclenol as a Novel Bacterial Histidine Biosynthesis Inhibitor against Invasive and Biofilm-Forming Uropathogenic Escherichia coli Kaur, Harpreet Chaudhary, Naveen Modgil, Vinay Kalia, Manmohit Kant, Vishal Mohan, Balvinder Bhatia, Alka Taneja, Neelam Antibiotics (Basel) Article Globally, urinary tract infections (UTIs) are one of the most frequent bacterial infections. Uropathogenic Escherichia coli (UPEC) are the predominant etiological agents causing community and healthcare-associated UTIs. Biofilm formation is an important pathogenetic mechanism of UPEC responsible for chronic and recurrent infections. The development of high levels of antimicrobial resistance (AMR) among UPEC has complicated therapeutic management. Newer antimicrobial agents are needed to tackle the increasing trend of AMR and inhibit biofilms. Heraclenol is a natural furocoumarin compound that inhibits histidine biosynthesis selectively. In this study, for the first time, we have demonstrated the antimicrobial and antibiofilm activity of heraclenol against UPEC. The drug reduced the bacterial load in the murine catheter UTI model by ≥4 logs. The drug effectively reduced bacterial loads in kidney, bladder, and urine samples. On histopathological examination, heraclenol treatment showed a reversal of inflammatory changes in the bladder and kidney tissues. It reduced the biofilm formation by 70%. The MIC value of heraclenol was observed to be high (1024 µg/mL), though the drug at MIC concentration did not have significant cytotoxicity on the Vero cell line. Further molecular docking revealed that heraclenol binds to the active site of the HisC, thereby preventing its activation by native substrate, which might be responsible for its antibacterial and antibiofilm activity. Since the high MIC of heraclenol is not achievable clinically in human tissues, further chemical modifications will be required to lower the drug’s MIC value and increase its potency. Alternatively, its synergistic action with other antimicrobials may also be studied. MDPI 2023-01-06 /pmc/articles/PMC9854483/ /pubmed/36671311 http://dx.doi.org/10.3390/antibiotics12010110 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kaur, Harpreet Chaudhary, Naveen Modgil, Vinay Kalia, Manmohit Kant, Vishal Mohan, Balvinder Bhatia, Alka Taneja, Neelam In Vitro and In Vivo Studies of Heraclenol as a Novel Bacterial Histidine Biosynthesis Inhibitor against Invasive and Biofilm-Forming Uropathogenic Escherichia coli |
title | In Vitro and In Vivo Studies of Heraclenol as a Novel Bacterial Histidine Biosynthesis Inhibitor against Invasive and Biofilm-Forming Uropathogenic Escherichia coli |
title_full | In Vitro and In Vivo Studies of Heraclenol as a Novel Bacterial Histidine Biosynthesis Inhibitor against Invasive and Biofilm-Forming Uropathogenic Escherichia coli |
title_fullStr | In Vitro and In Vivo Studies of Heraclenol as a Novel Bacterial Histidine Biosynthesis Inhibitor against Invasive and Biofilm-Forming Uropathogenic Escherichia coli |
title_full_unstemmed | In Vitro and In Vivo Studies of Heraclenol as a Novel Bacterial Histidine Biosynthesis Inhibitor against Invasive and Biofilm-Forming Uropathogenic Escherichia coli |
title_short | In Vitro and In Vivo Studies of Heraclenol as a Novel Bacterial Histidine Biosynthesis Inhibitor against Invasive and Biofilm-Forming Uropathogenic Escherichia coli |
title_sort | in vitro and in vivo studies of heraclenol as a novel bacterial histidine biosynthesis inhibitor against invasive and biofilm-forming uropathogenic escherichia coli |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854483/ https://www.ncbi.nlm.nih.gov/pubmed/36671311 http://dx.doi.org/10.3390/antibiotics12010110 |
work_keys_str_mv | AT kaurharpreet invitroandinvivostudiesofheraclenolasanovelbacterialhistidinebiosynthesisinhibitoragainstinvasiveandbiofilmforminguropathogenicescherichiacoli AT chaudharynaveen invitroandinvivostudiesofheraclenolasanovelbacterialhistidinebiosynthesisinhibitoragainstinvasiveandbiofilmforminguropathogenicescherichiacoli AT modgilvinay invitroandinvivostudiesofheraclenolasanovelbacterialhistidinebiosynthesisinhibitoragainstinvasiveandbiofilmforminguropathogenicescherichiacoli AT kaliamanmohit invitroandinvivostudiesofheraclenolasanovelbacterialhistidinebiosynthesisinhibitoragainstinvasiveandbiofilmforminguropathogenicescherichiacoli AT kantvishal invitroandinvivostudiesofheraclenolasanovelbacterialhistidinebiosynthesisinhibitoragainstinvasiveandbiofilmforminguropathogenicescherichiacoli AT mohanbalvinder invitroandinvivostudiesofheraclenolasanovelbacterialhistidinebiosynthesisinhibitoragainstinvasiveandbiofilmforminguropathogenicescherichiacoli AT bhatiaalka invitroandinvivostudiesofheraclenolasanovelbacterialhistidinebiosynthesisinhibitoragainstinvasiveandbiofilmforminguropathogenicescherichiacoli AT tanejaneelam invitroandinvivostudiesofheraclenolasanovelbacterialhistidinebiosynthesisinhibitoragainstinvasiveandbiofilmforminguropathogenicescherichiacoli |